Category list : Atrial fibrillation
Sort by: Newest first Oldest first A-Z Z-A
-
Pharmacist-led atrial fibrillation case finding programme prevents an estimated 90 strokes Subscription
A pharmacist-led programme to identify patients with atrial fibrillation may have prevented up to 90 AF-related strokes across 23 clinical commissioning group areas, NHS England has said.
-
Charity expresses patient safety concerns over draft atrial fibrillation guidance from NICE Subscription
A UK charity has expressed patient safety concerns over draft guidance issued by the National Institute for Health and Care Excellence on the management of atrial fibrillation.
-
Increased anticoagulation is reducing the rate of stroke and saving nearly £300 per patient treated, study suggests Subscription
The NHS is saving nearly £300 per patient on oral anticoagulation for atrial fibrillation, despite rising prescription costs for the medicine, owing to a decline in AF-related strokes.
-
Pharmacists could screen patients for AF during flu vaccination appointments, study suggests Subscription
Screening for atrial fibrillation could be carried out during flu vaccination appointments to increase early detection rates, a feasibility study has suggested.
-
Apixaban may be more effective and safer than rivaroxaban, research suggests Subscription
Adults with non-valvular atrial fibrillation prescribed apixaban have a lower rate of ischaemic stroke and systemic blood clots compared with those prescribed rivaroxaban, according to a retrospective cohort study in Annals of Internal Medicine.
-
Lower-GI bleeding should be investigated in anticoagulated patients, researchers say Subscription
Lower gastrointestinal bleeding in patients with atrial fibrillation who are being treated with oral anticoagulants is associated with a higher risk of being diagnosed with colorectal cancer, a study published in the European Heart Journal suggests.
-
Apixaban safer than warfarin for patients regardless of stroke history Subscription
Apixaban is associated with less major bleeding, death and hospitalisation than warfarin, regardless of a patient’s stroke history, a secondary analysis of the AUGUSTUS trial has indicated.
-
Patients taking anticoagulants feel excluded from therapy decisions Subscription
Patients with atrial fibrillation report several negative experiences associated with changes to their anticoagulation therapy — something that shared decision-making and patient education could help to address, research has suggested.
-
Forgotten patients: thousands left on risky anticoagulant combinations Subscription
Combinations of drugs involving anticoagulants are one of the most frequent causes of medicine-related hospital admissions, but pharmacists can help reduce the risk.
-
Pharmacists to identify AF patients at risk of stroke in £9m NHS England programme Subscription
Specialist pharmacists across 23 areas in England will help to identify patients with atrial fibrillation who are at risk of stroke and could benefit from medication, under a £9m programme announced by NHS England.
-
Depression linked to atrial fibrillation diagnosis Subscription
Depression is associated with an increased likelihood of atrial fibrillation diagnosis, according to a study published in the European Journal of Preventive Cardiology.
-
Sleep disruption linked to atrial fibrillation risk Subscription
Sleep disruption is an important risk factor for developing atrial fibrillation, study results show.
-
Pharmacists in a multidisciplinary atrial fibrillation clinic Subscription
Atrial fibrillation (AF) is the most common cardiac rhythm disturbance and increases in prevalence with advancing age. Each year, Tallaght University Hospital in Dublin assesses and admits over 400 patients with stroke and transient ischemic attack. AF is implicated as a causative factor in 33% of these cases. An AF-related stroke is more likely to be fatal, disabling and recurrent than a non-AF related stroke. The risk of AF-related stroke is greatly reduced, however, by early detection ...
-
Anticoagulant prescribing for AF patients with high stroke risk more than doubles Subscription
GP prescribing of anticoagulants for the treatment of patients with atrial fibrillation and a high risk of stroke more than doubled between 2000 and 2016, from 35.4% to 75.5%, according to research published in July 2018.
-
Uncertainty over anticoagulation risks and benefits in CKD patients with AF Subscription
The risk of both stroke and haemorrhage increases as chronic kidney disease progresses, which can complicate the decision on whether to begin anticoagulation in those with concomitant atrial fibrillation.
-
Primary-care overprescribing of rivaroxaban in patients without atrial fibrillation Subscription
There is a national prescribing trend for rivaroxaban (Xarelto; Bayer), one of four drugs known as direct oral anticoagulants (DOACs), and prescription is steadily rising. The drug has six licensed indications, with four different dosages and at least five possible durations of therapy, depending on the condition being treated. Anecdotal evidence suggests that some patients have inadvertently remained on rivaroxaban in the long term in cases where the drug had been indicated for only ...
-
Anticoagulants could cut the risk of dementia for patients with atrial fibrillation, researchers find
Oral anticoagulants are associated with a significant reduction in the risk of dementia in patients with atrial fibrillation (AF), according to a study published in the European Heart Journal.
-
Pharmacists screening for AF in hi-tech partnership
Pharmacists are to use hand-held devices to test patients for atrial fibrillation (AF) as part of a hi-tech partnership in London.
-
Intracranial haemorrhage risk of warfarin unrelated to INR control Subscription
Study results show that choosing apixaban over warfarin could reduce the risk of anticoagulation-related intracranial haemorrhage.
-
Dagibatran carries reduced fracture risk compared with warfarin Subscription
Among patients with nonvalvular atrial fibrillation, study data show the use of dabigatran rather than warfarin was associated with a lower risk of osteoporotic fracture.
Show 10 per page20 per page50 per page